Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized vs Spray Lidocaine for EGD
NCT02317770Phase 4Unknown
- Sponsor
- Mahidol University
- Start
- Nov 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lidocaine 10% oropharyngeal spray, sponsored by Mahidol University. Primary endpoint: Success rate of the procedure. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
Beyond the preview
Go deeper on NCT02317770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317770.